| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |